在对抗肺癌的斗争中,将奇托及其衍生品作为武器
Haitham Amin1, Islam M Ibrahim2, Emad H M Hassanein3
1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Azhar University, Assiut 71524, Egypt.
International journal of biological macromolecules
|June 6, 2024
概括
奇托为肺癌的传统化疗提供了一个有希望的替代方案. 这种生物聚合物可以被设计成纳米颗粒,有效地向和消除LC细胞,改善治疗结果.
科学领域:
- 生物材料科学 生物材料科学
- 在瘤学瘤学.
- 纳米技术纳米技术
背景情况:
- 肺癌 (LC) 是一个重大的全球健康挑战,常规化疗药物具有较差的选择性和严重的副作用.
- 传统化疗的不良影响可能会加剧患者的痛苦,并损害健康的组织,突出需要改进的治疗策略.
研究的目的:
- 审查作为肺癌 (LC) 治疗药物输送载体的奇托的实用性.
- 探索基托基配方在提高肺癌治疗疗效方面的潜力.
主要方法:
- 对癌症治疗中素应用的现有文献的综述.
- 分析基托桑在制造纳米颗粒 (聚合物,脂质),纳米复合材料和其他先进的输送系统中的作用.
- 检查基托桑的功能化用于向药物输送和治疗剂的整合.
主要成果:
- 奇托桑作为一个多功能平台,用于开发用于肺癌的先进药物输送系统.
- 包括纳米颗粒和纳米复合材料在内的基托桑基配方在向和杀死肺癌细胞方面表现出有效性.
- 各种素配方,如聚合NP,脂性NP和光疗剂,在LC治疗中显示出潜力.
结论:
- 奇托是一种非常适合开发用于肺癌治疗的新型药物输送载体的生物材料.
- 基托桑基配方代表了对抗肺癌的重大进步,提供了更好的疗效和向细胞死亡.
- 寻求用于肺癌的创新药物输送解决方案的研究人员应该考虑素作为主要候选材料.
更多相关视频
05:55Synthesis and Characterization of Placental Chondroitin Sulfate A plCSA-Targeting Lipid-Polymer Nanoparticles
Published on: September 18, 2018
8.7K
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
347
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K